(R)-3-((2S,3S)-3-((S)-2-((S)-2-(cyclopropanecarboxamido)-2-phenylacetamido)-3,3-dimethylbutanamido)-2-hydroxy-4-phenylbutanoyl)-N-isobutyl-5,5-dimethylthiazolidine-4-carboxamide

ID: ALA501813

Chembl Id: CHEMBL501813

PubChem CID: 44593403

Max Phase: Preclinical

Molecular Formula: C38H53N5O6S

Molecular Weight: 707.94

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Synonyms: KNI-10575 | CHEMBL501813|KNI-10575|BDBM50242955|(R)-3-((2S,3S)-3-((S)-2-((S)-2-(cyclopropanecarboxamido)-2-phenylacetamido)-3,3-dimethylbutanamido)-2-hydroxy-4-phenylbutanoyl)-N-isobutyl-5,5-dimethylthiazolidine-4-carboxamide|(R)-N-Isobutyl-3-{{(2S,3S)-3-{(2S)-2-[(2S)-2-cyclopropanecarbonylamino-2-phenyl]acetylamino-3,3-dimethyl}-butanoylamino-2-hydroxy-4-phenyl}}butanoyl-5,5-dimethyl-1,3-thiazolidine-4-carboxamide

Canonical SMILES:  CC(C)CNC(=O)[C@H]1N(C(=O)[C@@H](O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)C2CC2)c2ccccc2)C(C)(C)C)CSC1(C)C

Standard InChI:  InChI=1S/C38H53N5O6S/c1-23(2)21-39-35(48)31-38(6,7)50-22-43(31)36(49)29(44)27(20-24-14-10-8-11-15-24)40-34(47)30(37(3,4)5)42-33(46)28(25-16-12-9-13-17-25)41-32(45)26-18-19-26/h8-17,23,26-31,44H,18-22H2,1-7H3,(H,39,48)(H,40,47)(H,41,45)(H,42,46)/t27-,28-,29-,30+,31+/m0/s1

Standard InChI Key:  MDDJIKIYQOCBRC-DYFQPDDQSA-N

Associated Targets(non-human)

Protease (18 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
prt Protease (104 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
protease Protease (2551 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 707.94Molecular Weight (Monoisotopic): 707.3717AlogP: 3.33#Rotatable Bonds: 14
Polar Surface Area: 156.94Molecular Species: NEUTRALHBA: 7HBD: 5
#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 5#RO5 Violations (Lipinski): 2
CX Acidic pKa: 11.74CX Basic pKa: CX LogP: 3.51CX LogD: 3.51
Aromatic Rings: 2Heavy Atoms: 50QED Weighted: 0.20Np Likeness Score: 0.21

References

1. Zhang M, Nguyen JT, Kumada HO, Kimura T, Cheng M, Hayashi Y, Kiso Y..  (2008)  Locking the two ends of tetrapeptidic HTLV-I protease inhibitors inside the enzyme.,  16  (14): [PMID:18558491] [10.1016/j.bmc.2008.05.052]
2. Zhang M, Nguyen JT, Kumada HO, Kimura T, Cheng M, Hayashi Y, Kiso Y..  (2008)  Synthesis and activity of tetrapeptidic HTLV-I protease inhibitors possessing different P3-cap moieties.,  16  (10): [PMID:18400502] [10.1016/j.bmc.2008.03.055]

Source